High dose cabergoline for small prolactin tumors in women
Treatments studied
Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a premenopausal woman over 18 years old.
- You have a small pituitary tumor (less than 1 cm) seen on an MRI.
- You have high prolactin levels (at least twice the normal maximum).
- You have not received any treatment for this condition before.
- If you are sexually active with a male partner, you must agree to use effective birth control during the study.
- You are not pregnant, planning to get pregnant, or using hormonal birth control pills in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
This study looks at how changes in estrogen before diagnosis affect the growth of prolactin-secreting pituitary tumors (prolactinomas). The goal is to understand why some tumors are larger than others.
This research study investigates tumors and disorders of the pituitary gland (a small gland that controls many body hormones) and related areas of the brain. You may qualify if you have a pituitary tumor or disorder, or if you have a family history of these conditions.
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
This trial tests if cabergoline can help reduce high prolactin levels caused by antipsychotic medications in people with schizophrenia. It may be an option if you have symptoms like breast tenderness, milk production, or sexual side effects.
This trial tests if cabergoline, a medicine, can help shrink nonfunctioning pituitary adenomas (benign tumors on the pituitary gland that don't produce excess hormones). It may be an option for people who have not had prior radiation or surgery, and whose tumors are at least 0.5 cm in size.
Hear when a new Prolactinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.